Supriya Lifescience Limited reports a change in its board or management
In short
Supriya Lifescience Limited informed the exchange on November 6, 2026, that it has appointed Mr Mangesh Vaze as Chief Operating Officer and Senior Management Personnel, effective the same day. No figures or breakdowns were given. In simple terms, the company has brought in a new top operations executive to help run the business. The appointment took effect on November 6, 2026, with no separate closing date or validity period stated.
Why it matters
A change at the leadership or audit level — worth checking who's departing/joining and whether the filing gives a reason. This brief was written from the filing itself: at the time of writing, no publisher in our feed had covered it.